Wish A Pos Australia

Alterity Therapeutics, based in Melbourne, Victoria, is dedicated to pioneering innovative therapies for individuals affected by neurodegenerative diseases. Their lead drug candidate, ATH434, has shown promise in animal models for treating Parkinson's disease and is currently undergoing evaluation in clinical trials. The company aims to disrupt the traditional trajectory of these debilitating conditions, striving to create healthier alternatives for those living with neurodegenerative disorders. With a commitment to advancing first-in-class treatments, Alterity Therapeutics is at the forefront of neurotherapeutics research. Generated from the website